神経血管デバイス市場：疾患病態、デバイス、エンドユーザー別-2025-2030年の世界予測

神経血管デバイス市場は、2023年に32億1,000万米ドルと評価され、2024年には34億4,000万米ドルに達すると予測され、CAGR 7.34％で成長し、2030年には52億8,000万米ドルに達すると予測されています。

神経血管デバイス市場には、脳の血管や脈管構造に影響を及ぼす疾患や状態を診断・治療するためのソリューションが含まれます。脳卒中や動脈瘤などの脳血管障害が増加した結果、革新的な治療技術の必要性がかつてないほど高まっています。これらの機器の用途は、ステントやコイル・システムのような低侵襲手術器具から、正確な疾患発見に必要な診断機器まで多岐にわたる。エンドユーザーは主に、神経血管障害に携わる病院、専門クリニック、研究機関などです。市場の成長には、神経疾患の有病率の増加、医療技術の進歩、世界の老人人口の増加といった主な要因が寄与しています。その他の影響要素としては、新興国における意識の高まりやヘルスケアインフラの拡大が挙げられます。潜在的なビジネスチャンスは、診断強化のためのAIと機械学習の統合、患者へのリーチを向上させる遠隔医療プラットフォーム、アジア太平洋とラテンアメリカの過疎市場への戦略的参入にあります。しかし、厳しい規制遵守や先端機器の高コストといった課題が、成長の大きな障害となっています。研究開発への投資は、こうした課題を軽減し、費用対効果の高いソリューションの開発や規制経路の合理化に役立ちます。技術革新の最良の道筋は、生体吸収性ステントや次世代ポリマーコイルなどのスマート神経血管インターベンションの開発や、データ解析や画像診断法の改善による患者固有の分析の進歩にあります。この市場の特性は、急速な技術進歩と強力な競合であり、企業は機敏さを維持する必要があります。そのため、企業は最先端技術のより良い適応のためにヘルスケアプロバイダーとのコラボレーションに注力し、競争優位性を維持するために規制の変更に警戒し続けることが推奨されます。患者の転帰データを理解し、提供する製品を継続的に改善することは、このダイナミックな状況下で長期的な成功を収めるための基本です。

市場力学：急速に進化する神経血管デバイス市場の主要市場インサイトを公開

神経血管デバイス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 脳動脈瘤および神経疾患の増加
  • 低侵襲脳手術に対する需要の高まり
• 市場抑制要因
  • 神経血管インターベンションとデバイスに関連する高コスト
• 市場機会
  • 神経血管治療分野における新たな調査活動と技術的進歩
  • 進行中の製品開発と神経血管デバイスの承認
• 市場の課題
  • 世界中の神経外科医の数が限られていること

ポーターの5つの力：神経血管デバイス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：神経血管デバイス市場における外部からの影響の把握

外部マクロ環境要因は、神経血管デバイス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析神経血管デバイス市場における競合情勢の把握

神経血管デバイス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス神経血管デバイス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、神経血管デバイス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨神経血管デバイス市場における成功への道筋を描く

神経血管デバイス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大の可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 脳動脈瘤や神経疾患の発生率増加
    • 脳外科手術における低侵襲手術の需要増加
  • 抑制要因
    • 神経血管介入およびデバイスに関連する高コスト
  • 機会
    • 神経血管治療分野における新たな調査活動と技術の進歩
    • 神経血管デバイスの継続的な製品開発と承認
  • 課題
    • 世界中で脳神経外科医の数が限られている
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 神経血管デバイス市場疾患病理学

• 動脈瘤
• 動静脈奇形および瘻孔
• 虚血性脳卒中
• 狭窄

第7章 神経血管デバイス市場デバイス別

• 脳血管形成術およびステント留置システム
  • 塞栓コイル
  • フローダイバータ
  • 液体塞栓剤
• 脳塞栓術および動脈瘤コイル塞栓装置
  • 頸動脈ステント
  • 塞栓保護システム
• 神経血栓除去装置
  • 血栓除去装置
  • 吸引装置
  • 血管スネア
• サポートデバイス
  • マイクロカテーテル
  • マイクロガイドワイヤー

第8章 神経血管デバイス市場：エンドユーザー別

• 外来手術センター
• 病院
• 専門クリニック

第9章 南北アメリカの神経血管デバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の神経血管デバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの神経血管デバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Acandis GmbH
• AngioDynamics Inc.
• Artio Medical, Inc.
• B. Braun Melsungen AG
• BALT Group
• Boston Scientific Corporation
• Cerus Endovascular Inc.
• CONMED Corporation
• Cook Medical Group
• Endologix Inc.
• Evasc Medical Systems Corp.
• Integra Lifesciences Corporation
• iVascular S.L.U.
• Johnson & Johnson Services, Inc.
• Koninklijke Philips N.V.
• Lepu Medical Technology（Beijing）Co.,Ltd.
• Medical Murray
• Medtronic PLC
• Microvention Inc.
• Penumbra, Inc.
• Phenox GmbH by Wallaby Medical
• Rapid Medical Ltd.
• Scientia Vascular, Inc.
• Secant Group, LLC
• Stryker Corporation
• Terumo Corporation
• W. L. Gore & Associates, Inc.
• Zeus Company Inc.

LIST OF FIGURES

• FIGURE 1. NEUROVASCULAR DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. NEUROVASCULAR DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. NEUROVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. NEUROVASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NEUROVASCULAR DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NEUROVASCULAR DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION & FISTULAS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY STENOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY LIQUID EMBOLIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIC PROTECTION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CLOT RETRIEVAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SUCTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY VASCULAR SNARES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MICRO CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MICRO GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 58. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 59. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 60. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 61. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 62. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 63. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 87. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 88. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 89. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 90. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 91. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 92. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 93. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 96. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 97. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 98. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 99. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 100. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 103. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 104. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 105. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 106. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 107. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 109. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 110. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 111. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 112. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 113. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 114. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 116. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 117. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 118. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 119. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 120. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 121. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 124. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 125. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 126. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 127. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 128. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 130. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 131. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 132. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 133. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 134. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 135. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 137. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 138. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 139. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 140. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 141. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 142. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 144. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 145. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 146. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 147. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 148. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 149. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 151. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 152. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 153. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 154. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 155. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 156. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 158. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 159. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 160. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 161. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 162. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 163. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 165. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 166. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 167. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 168. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 169. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 170. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 172. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 179. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 180. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 181. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 182. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 183. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 184. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 185. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 187. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 188. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 189. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 190. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 191. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 192. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 193. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 194. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 195. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 196. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 197. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 198. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 199. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 200. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 201. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 202. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 203. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 204. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 205. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 206. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 207. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 208. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 209. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 210. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 211. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 212. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 213. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 214. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 215. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 216. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 217. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 218. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 219. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 220. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 221. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 222. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 223. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 224. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 225. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 226. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 227. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 228. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 229. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 230. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 231. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 232. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 233. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 234. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 235. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 236. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 237. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 238. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 239. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 240. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 241. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 242. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 243. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 244. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 245. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 246. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 247. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 248. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 249. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 250. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 251. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 252. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 253. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 254. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 255. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 256. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 257. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 258. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 259. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 260. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 261. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 262. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 263. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 264. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 265. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 266. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 267. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 268. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 269. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 270. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 271. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 272. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 273. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 274. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 275. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 276. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 277. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 278. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 279. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 280. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 281. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 282. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 283. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 284. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 285. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 286. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 287. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 288. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 289. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 290. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 291. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 292. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 293. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 294. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 295. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 296. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 297. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 298. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 299. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 300. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 301. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 302. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 303. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 304. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 305. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
• TABLE 306. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 307. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 308. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
• TABLE 309. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECT

The Neurovascular Devices Market was valued at USD 3.21 billion in 2023, expected to reach USD 3.44 billion in 2024, and is projected to grow at a CAGR of 7.34%, to USD 5.28 billion by 2030.

The neurovascular devices market encompasses solutions designed to diagnose and treat diseases and conditions affecting the blood vessels and vascular structures in the brain. As a result of rising cerebrovascular incidents such as strokes and aneurysms, the necessity for innovative therapeutic technologies has never been greater. Applications of these devices span from minimally invasive surgical tools like stents and coil systems to diagnostic equipment necessary for accurate disease detection. End-users primarily include hospitals, specialized clinics, and research institutions engaged in neurovascular disorders. Market growth is fueled by key factors such as the increasing prevalence of neurological disorders, advancements in medical technology, and the growing geriatric population globally. Other influencing elements include rising awareness and the expansion of healthcare infrastructure in emerging economies. Potential opportunities lie in the integration of AI and machine learning for enhanced diagnostics, telemedicine platforms improving patient reach, and strategically entering underpenetrated markets in Asia-Pacific and Latin America. However, challenges such as stringent regulatory compliance and the high cost of advanced devices pose significant hurdles to growth. Investments in R&D can mitigate these challenges, helping develop cost-effective solutions and streamlining regulatory pathways. The best avenues for innovation lie in the development of smart neurovascular interventions, such as bioresorbable stents and next-gen polymer coils, as well as advancements in patient-specific analysis through data analytics and improved imaging methods. The nature of this market is characterized by rapid technological advancement and strong competition, requiring firms to remain agile. Therefore, businesses are advised to focus on collaboration with healthcare providers for better adaptation of cutting-edge technologies and to remain vigilant of regulatory changes to sustain a competitive advantage. Understanding patient outcome data and continuously improving product offerings will be fundamental to achieving long-term success in this dynamic landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neurovascular Devices Market

The Neurovascular Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidences of a brain aneurysm and neurological disorders
  • Rising demand for minimally invasive procedures for brain surgeries
• Market Restraints
  • High cost associated with the neurovascular interventions and devices
• Market Opportunities
  • Emerging research activities and technological advancements in the field of neurovascular therapies
  • Ongoing product development and approvals of neurovascular devices
• Market Challenges
  • Limited availability of neurosurgeons across the globe

Porter's Five Forces: A Strategic Tool for Navigating the Neurovascular Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neurovascular Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neurovascular Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neurovascular Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neurovascular Devices Market

A detailed market share analysis in the Neurovascular Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neurovascular Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neurovascular Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neurovascular Devices Market

A strategic analysis of the Neurovascular Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neurovascular Devices Market, highlighting leading vendors and their innovative profiles. These include Acandis GmbH, AngioDynamics Inc., Artio Medical, Inc., B. Braun Melsungen AG, BALT Group, Boston Scientific Corporation, Cerus Endovascular Inc., CONMED Corporation, Cook Medical Group, Endologix Inc., Evasc Medical Systems Corp., Integra Lifesciences Corporation, iVascular S.L.U., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Lepu Medical Technology(Beijing)Co.,Ltd., Medical Murray, Medtronic PLC, Microvention Inc., Penumbra, Inc., Phenox GmbH by Wallaby Medical, Rapid Medical Ltd., Scientia Vascular, Inc., Secant Group, LLC, Stryker Corporation, Terumo Corporation, W. L. Gore & Associates, Inc., and Zeus Company Inc..

Market Segmentation & Coverage

This research report categorizes the Neurovascular Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Disease Pathology, market is studied across Aneurysm, Arteriovenous Malformation & Fistulas, Ischemic Stroke, and Stenosis.
• Based on Devices, market is studied across Cerebral Angioplasty & Stenting Systems, Cerebral Embolization & Aneurysm Coiling Devices, Neurothrombectomy Devices, and Support Devices. The Cerebral Angioplasty & Stenting Systems is further studied across Embolic Coils, Flow Diverters, and Liquid Embolic Agents. The Cerebral Embolization & Aneurysm Coiling Devices is further studied across Carotid Artery Stents and Embolic Protection Systems. The Neurothrombectomy Devices is further studied across Clot Retrieval Devices, Suction Devices, and Vascular Snares. The Support Devices is further studied across Micro Catheters and Micro Guidewires.
• Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialized Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of a brain aneurysm and neurological disorders
    • 5.1.1.2. Rising demand for minimally invasive procedures for brain surgeries
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the neurovascular interventions and devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging research activities and technological advancements in the field of neurovascular therapies
    • 5.1.3.2. Ongoing product development and approvals of neurovascular devices
  • 5.1.4. Challenges
    • 5.1.4.1. Limited availability of neurosurgeons across the globe
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Neurovascular Devices Market, by Disease Pathology

• 6.1. Introduction
• 6.2. Aneurysm
• 6.3. Arteriovenous Malformation & Fistulas
• 6.4. Ischemic Stroke
• 6.5. Stenosis

7. Neurovascular Devices Market, by Devices

• 7.1. Introduction
• 7.2. Cerebral Angioplasty & Stenting Systems
  • 7.2.1. Embolic Coils
  • 7.2.2. Flow Diverters
  • 7.2.3. Liquid Embolic Agents
• 7.3. Cerebral Embolization & Aneurysm Coiling Devices
  • 7.3.1. Carotid Artery Stents
  • 7.3.2. Embolic Protection Systems
• 7.4. Neurothrombectomy Devices
  • 7.4.1. Clot Retrieval Devices
  • 7.4.2. Suction Devices
  • 7.4.3. Vascular Snares
• 7.5. Support Devices
  • 7.5.1. Micro Catheters
  • 7.5.2. Micro Guidewires

8. Neurovascular Devices Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Hospitals
• 8.4. Specialized Clinics

9. Americas Neurovascular Devices Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Neurovascular Devices Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Neurovascular Devices Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Acandis GmbH
• 2. AngioDynamics Inc.
• 3. Artio Medical, Inc.
• 4. B. Braun Melsungen AG
• 5. BALT Group
• 6. Boston Scientific Corporation
• 7. Cerus Endovascular Inc.
• 8. CONMED Corporation
• 9. Cook Medical Group
• 10. Endologix Inc.
• 11. Evasc Medical Systems Corp.
• 12. Integra Lifesciences Corporation
• 13. iVascular S.L.U.
• 14. Johnson & Johnson Services, Inc.
• 15. Koninklijke Philips N.V.
• 16. Lepu Medical Technology(Beijing)Co.,Ltd.
• 17. Medical Murray
• 18. Medtronic PLC
• 19. Microvention Inc.
• 20. Penumbra, Inc.
• 21. Phenox GmbH by Wallaby Medical
• 22. Rapid Medical Ltd.
• 23. Scientia Vascular, Inc.
• 24. Secant Group, LLC
• 25. Stryker Corporation
• 26. Terumo Corporation
• 27. W. L. Gore & Associates, Inc.
• 28. Zeus Company Inc.